Bids roll in for Germany's Ratiopharm

11/13/2009 | Wall Street Journal, The

Germany's generic-drug maker Ratiopharm is for sale and already has received several bids. Drugmakers Pfizer, Teva Pharmaceutical Industries, Sanofi-Aventis, joint venture Goldman Sachs-Advent and private-equity firms TPG, Permira and Kohlberg Kravis Roberts have placed offers for the family-owned company, according to various reports.

View Full Article in:

Wall Street Journal, The